301 related articles for article (PubMed ID: 16818691)
1. Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.
Beer AJ; Haubner R; Sarbia M; Goebel M; Luderschmidt S; Grosu AL; Schnell O; Niemeyer M; Kessler H; Wester HJ; Weber WA; Schwaiger M
Clin Cancer Res; 2006 Jul; 12(13):3942-9. PubMed ID: 16818691
[TBL] [Abstract][Full Text] [Related]
2. [18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck.
Beer AJ; Grosu AL; Carlsen J; Kolk A; Sarbia M; Stangier I; Watzlowik P; Wester HJ; Haubner R; Schwaiger M
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6610-6. PubMed ID: 18006761
[TBL] [Abstract][Full Text] [Related]
3. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.
Beer AJ; Niemeyer M; Carlsen J; Sarbia M; Nährig J; Watzlowik P; Wester HJ; Harbeck N; Schwaiger M
J Nucl Med; 2008 Feb; 49(2):255-9. PubMed ID: 18199623
[TBL] [Abstract][Full Text] [Related]
4. Imaging of integrin alpha(v)beta(3) expression in patients with malignant glioma by [18F] Galacto-RGD positron emission tomography.
Schnell O; Krebs B; Carlsen J; Miederer I; Goetz C; Goldbrunner RH; Wester HJ; Haubner R; Pöpperl G; Holtmannspötter M; Kretzschmar HA; Kessler H; Tonn JC; Schwaiger M; Beer AJ
Neuro Oncol; 2009 Dec; 11(6):861-70. PubMed ID: 19401596
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and pharmacokinetics of the alphavbeta3-selective tracer 18F-galacto-RGD in cancer patients.
Beer AJ; Haubner R; Goebel M; Luderschmidt S; Spilker ME; Wester HJ; Weber WA; Schwaiger M
J Nucl Med; 2005 Aug; 46(8):1333-41. PubMed ID: 16085591
[TBL] [Abstract][Full Text] [Related]
6. Comparison of integrin alphaVbeta3 expression and glucose metabolism in primary and metastatic lesions in cancer patients: a PET study using 18F-galacto-RGD and 18F-FDG.
Beer AJ; Lorenzen S; Metz S; Herrmann K; Watzlowik P; Wester HJ; Peschel C; Lordick F; Schwaiger M
J Nucl Med; 2008 Jan; 49(1):22-9. PubMed ID: 18077538
[TBL] [Abstract][Full Text] [Related]
7. PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.
Beer AJ; Pelisek J; Heider P; Saraste A; Reeps C; Metz S; Seidl S; Kessler H; Wester HJ; Eckstein HH; Schwaiger M
JACC Cardiovasc Imaging; 2014 Feb; 7(2):178-87. PubMed ID: 24412187
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of alphavbeta3 integrin-targeted positron emission tomography tracer 18F-galacto-RGD for imaging of vascular inflammation in atherosclerotic mice.
Laitinen I; Saraste A; Weidl E; Poethko T; Weber AW; Nekolla SG; Leppänen P; Ylä-Herttuala S; Hölzlwimmer G; Walch A; Esposito I; Wester HJ; Knuuti J; Schwaiger M
Circ Cardiovasc Imaging; 2009 Jul; 2(4):331-8. PubMed ID: 19808614
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of early αvβ3 integrin expression predicts long-term left-ventricle remodeling after myocardial infarction in rats.
Sherif HM; Saraste A; Nekolla SG; Weidl E; Reder S; Tapfer A; Rudelius M; Higuchi T; Botnar RM; Wester HJ; Schwaiger M
J Nucl Med; 2012 Feb; 53(2):318-23. PubMed ID: 22302965
[TBL] [Abstract][Full Text] [Related]
10. PET-based human dosimetry of 18F-galacto-RGD, a new radiotracer for imaging alpha v beta3 expression.
Beer AJ; Haubner R; Wolf I; Goebel M; Luderschmidt S; Niemeyer M; Grosu AL; Martinez MJ; Wester HJ; Weber WA; Schwaiger M
J Nucl Med; 2006 May; 47(5):763-9. PubMed ID: 16644745
[TBL] [Abstract][Full Text] [Related]
11. Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.
Kitajima K; Murakami K; Yamasaki E; Kaji Y; Sugimura K
Ann Nucl Med; 2008 Jul; 22(6):505-12. PubMed ID: 18670857
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD.
Haubner R; Weber WA; Beer AJ; Vabuliene E; Reim D; Sarbia M; Becker KF; Goebel M; Hein R; Wester HJ; Kessler H; Schwaiger M
PLoS Med; 2005 Mar; 2(3):e70. PubMed ID: 15783258
[TBL] [Abstract][Full Text] [Related]
13. Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer.
Gasparini G; Brooks PC; Biganzoli E; Vermeulen PB; Bonoldi E; Dirix LY; Ranieri G; Miceli R; Cheresh DA
Clin Cancer Res; 1998 Nov; 4(11):2625-34. PubMed ID: 9829725
[TBL] [Abstract][Full Text] [Related]
14. Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.
Ma BB; King A; Lo YM; Yau YY; Zee B; Hui EP; Leung SF; Mo F; Kam MK; Ahuja A; Kwan WH; Chan AT
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):714-20. PubMed ID: 17011447
[TBL] [Abstract][Full Text] [Related]
15. Imaging of delayed-type hypersensitivity reaction by PET and 18F-galacto-RGD.
Pichler BJ; Kneilling M; Haubner R; Braumüller H; Schwaiger M; Röcken M; Weber WA
J Nucl Med; 2005 Jan; 46(1):184-9. PubMed ID: 15632051
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-NODAGA-RGD is a suitable substitute for (18)F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process.
Pohle K; Notni J; Bussemer J; Kessler H; Schwaiger M; Beer AJ
Nucl Med Biol; 2012 Aug; 39(6):777-84. PubMed ID: 22444238
[TBL] [Abstract][Full Text] [Related]
17. PET imaging of αvβ3 expression in cancer patients.
Beer AJ; Schwaiger M
Methods Mol Biol; 2011; 680():183-200. PubMed ID: 21153382
[TBL] [Abstract][Full Text] [Related]
18. Imaging of integrin alphavbeta3 expression.
Beer AJ; Schwaiger M
Cancer Metastasis Rev; 2008 Dec; 27(4):631-44. PubMed ID: 18523730
[TBL] [Abstract][Full Text] [Related]
19. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
Burtea C; Laurent S; Murariu O; Rattat D; Toubeau G; Verbruggen A; Vansthertem D; Vander Elst L; Muller RN
Cardiovasc Res; 2008 Apr; 78(1):148-57. PubMed ID: 18174291
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive assessment of inter-and intrapatient variability of integrin expression in metastasized prostate cancer by PET.
Beer AJ; Schwarzenböck SM; Zantl N; Souvatzoglou M; Maurer T; Watzlowik P; Kessler H; Wester HJ; Schwaiger M; Krause BJ
Oncotarget; 2016 May; 7(19):28151-9. PubMed ID: 27058620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
